By Abigail Townsend
Date: Wednesday 07 May 2025
(Sharecast News) - Shares in GSK and AstraZeneca came under pressure on Wednesday, after vaccine-sceptic Vinay Prasad was appointed to a key role at the US Food and Drug Administration.
Currency | US Dollars |
Share Price | $ 757.39 |
Change Today | $ 24.10 |
% Change | 3.29 % |
52 Week High | $960.02 |
52 Week Low | $715.56 |
Volume | 4,645,121 |
Shares Issued | 948.17m |
Market Cap | $718,134m |
Beta | 0.76 |
RiskGrade | 179 |
Strong Buy | 11 |
Buy | 10 |
Neutral | 5 |
Sell | 1 |
Strong Sell | 0 |
Total | 27 |
Time | Volume / Share Price |
15:59 | 100 @ $756.97 |
15:59 | 100 @ $757.00 |
15:59 | 100 @ $757.24 |
15:59 | 210 @ $756.97 |
15:59 | 210 @ $756.97 |
You are here: research